Ducaling, Menda O.
HRN: 16-41-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2024
CEFTRIAXONE 1G (VIAL)
06/05/2024
06/12/2024
IV
2gm
Q24h
Infected Wound, Left Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes